SCHEMBL25445653

SCHEMBL25445653

CCC(=O)c1cc(C(=O)NC)c(=O)n(Cc2ccccc2)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 18/20 0.81
BRD2 P25440 3/20 0.69
BRD3 Q15059 3/20 0.69
BRDT Q58F21 3/20 0.69
TRIM24 O15164 1/20 0.69
BRD1 O95696 1/20 0.69
CCL2 P13500 1/20 0.69
TAF1 P21675 1/20 0.69
SMARCA2 P51531 1/20 0.69
SMARCA4 P51532 1/20 0.69
BRPF1 P55201 1/20 0.69
EP300 Q09472 1/20 0.69
BPTF Q12830 1/20 0.69
CACNA1C Q13936 1/20 0.69
ATAD2 Q6PL18 1/20 0.69
PBRM1 Q86U86 1/20 0.69
TAF1L Q8IZX4 1/20 0.69
CREBBP Q92793 1/20 0.69
KAT2A Q92830 1/20 0.69
KAT2B Q92831 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18731597 0.90 BRD4 (1.00) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18584533 0.89 BRD4 (0.88) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL23318382 0.88 BRD4 (0.85) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18616892 0.87 BRD4 (1.00) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL28600411 0.86 BRD4 (0.88) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18616130 0.86 BRD4 (1.00) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18617021 0.85 BRD4 (0.81) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18616876 0.85 BRD4 (0.76) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL18701430 0.85 BRD4 (0.83) BRD4BRD2BRD3BRDTTRIM24
SCHEMBL23318233 0.84 BRD4 (0.80) BRD4BRD2BRD3BRDTTRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145782-A1 p53 MODULATORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145782-A1 p53 MODULATORS AND USES THEREOF TP53, TP53BP1, MDM2 BRD4 1654/4885BRD2 1339/4885BRD3 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.